H. Wilke
- Pulmonary and Respiratory Medicine top 10%
- Oncology
- Surgery
- Gastroenterology top 5%
- Cardiology and Cardiovascular Medicine
- Topics
- Gastric Cancer Management and Outcomes (9 papers)Metastasis and carcinoma case studies (6 papers)Lung Cancer Treatments and Mutations (5 papers)
In The Last Decade
H. Wilke
15 papers receiving 410 citations
Peers
Comparison fields: 5 of 46
- Pulmonary and Respiratory Medicine 285
- Oncology 211
- Surgery 178
- Gastroenterology 73
- Cardiology and Cardiovascular Medicine 71
Countries citing papers authored by H. Wilke
This map shows the geographic impact of H. Wilke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Wilke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Wilke more than expected).
Fields of papers citing papers by H. Wilke
This network shows the impact of papers produced by H. Wilke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Wilke. The network helps show where H. Wilke may publish in the future.
Co-authorship network of co-authors of H. Wilke
This figure shows the co-authorship network connecting the top 25 collaborators of H. Wilke. A scholar is included among the top collaborators of H. Wilke based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Wilke. H. Wilke is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 3 | |
| 2 | 16 | |
| 3 | 6 | |
| 4 | 7 | |
| 5 | 1 | |
| 6 | 37 | |
| 7 | 0 | |
| 8 | [Surgery of locally advanced non-small-cell bronchial cancer after intensive preoperative chemo-/radiotherapy]. | 2 |
| 9 | 89 | |
| 10 | Dose escalation of cisplatin (P), etoposide (E), and ifosfamide (I) with GM-CSF for advanced germ cell tumors. | 1 |
| 11 | 5 | |
| 12 | 238 | |
| 13 | 5 | |
| 14 | Advanced inoperable stomach cancer: a pilot study with the combination etoposide, adriamycin and cisplatin. | 10 |
| 15 | 1 | |
| 16 | 2 |
About H. Wilke
H. Wilke is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Otorhinolaryngology, having authored 16 papers that have together received 423 indexed citations. Recurring topics across this work include Gastric Cancer Management and Outcomes (9 papers), Metastasis and carcinoma case studies (6 papers) and Lung Cancer Treatments and Mutations (5 papers). The work is most often cited by research in Gastroenterology (73 citations), Pulmonary and Respiratory Medicine (285 citations) and Oncology (211 citations). H. Wilke has collaborated with scholars based in Germany and France. Frequent co-authors include U. Fink, W. Achterrath, P. Preusser, Jochen Meyer, H J Meyer, Luigi Lenaz, A. Heinicke, H. J. Stein, Christoph Schuhmacher and M. Stahl. Their work appears in journals such as Journal of Clinical Oncology, Cancer and European Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.